Watchlist

Watchlist
Ardelyx, Inc. (ARDX)
Midday Gainers / Losers (05/23/2018)
Gainers: WMLP +172% . AVGR +53% . CARA +32% . BDR +28% . TIF +20% . RL +17% . MDXG +16% . AMDA +14% . USAT +13% . DCAR +13% . More news on: Westmoreland Resource Partners, LP, Avinger, Cara Therapeutics Inc., Stocks on the move, , Read more …
Premarket Losers as of 9:10 am (5/23/2018)
RRGB -20% on Q1 earnings . More news on: Red Robin Gourmet Burgers, Inc., Pfenex, Ardelyx, Stocks on the move, , Read more …
Ardelyx down 9% on pricing common stock offering
Ardelyx (NASDAQ: ARDX ) prices its public offering of 12.5M shares of common stock at a price of $4.00 per share yielding gross proceeds of $50M. More news on: Ardelyx, Healthcare stocks news, Stocks on the move, Read more …
Ardelyx Announces Pricing of Public Offering of Common Stock
FREMONT, Calif. , May 22, 2018 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX) today announced the pricing of an underwritten public offering of 12,500,000 shares of its common stock at a public offering price of $4.00 per share, before underwriting discounts and commissions, for gross pro…
Midday Gainers / Losers (05/22/2018)
Gainers: CPAH +16% . CRMT +15% . MDXG +13% . NSTG +12% . SDR +12% . FWP +11% . ARQL +11% . GERN +11% . SMRT +11% . AVEO +10% . More news on: CounterPath Corporation, America's Car-Mart, Inc., MiMedx Group Inc., Stocks on the move, , Read more …
Ardelyx Raises $50 Million in Loan Agreement with Solar Capital and Bridge Bank
FREMONT, Calif. , May 21, 2018 /PRNewswire/ --Ardelyx, Inc. (Nasdaq: ARDX), today announced it has entered into a $50.0 million senior secured term loan facility with Solar Capital Ltd. and the Life Sciences Group at Bridge Bank, a division of Western Alliance Bank. The loan was f…
Ardelyx Announces Proposed Public Offering of Common Stock
FREMONT, Calif. , May 21, 2018 /PRNewswire/ --Ardelyx, Inc. (Nasdaq: ARDX), today announced that it has commenced an underwritten public offering of up to $50,000,000 of shares of its common stock. All of the shares to be sold in the offering will be offered by Ardelyx. In additio…
Ardelyx Looks Cheap But Not Without Risk
This article was co-authored by Stepan Lavrouk, an investment analyst with Almington Capital. Ardelyx ( ARDX ) is a clinical stage biopharmaceutical company specializing in the discovery, development and commercialization of small-molecule treatments for gastrointestinal (GI&#x20…
Ardelyx beats by $0.10
Ardelyx (NASDAQ: ARDX ): Q1 EPS of -$0.36 beats by $0.10 . More news on: Ardelyx, Earnings news and commentary, Healthcare stocks news, , Read more …
Ardelyx Reports First Quarter 2018 Financial Results and Recent Business Highlights
FREMONT, Calif. , May 8, 2018 /PRNewswire/ -- Ardelyx, Inc. (NASDAQ: ARDX), today reported business highlights and financial results for the first quarter ended March 31, 2018 . "The first quarter of 2018 has been about execution for Ardelyx," said Mike Raab , president and ch…
Ardelyx, Inc. (ARDX)